All In MedTech

FDA Clearance Tracker · P030006-S010

PROLIEVE THERMODILATATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 20, 2006 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 20, 2006

Approved

Time to decision

50 days

Received Dec 1, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030006-S010
Device name
PROLIEVE THERMODILATATION SYSTEM
Applicant location
Columbia, MD
Received
Dec 1, 2005
Decided
Jan 20, 2006
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P030006

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A NEW SANMINA-SCI CORPORATION MANUFACTURING SITE LOCATED IN HUNTSVILLE, ALABAMA TO MANUFACTURE THE PROLIEVE THERMODILATATION SYSTEM CONSOLE AND RECTAL TEMPERATURE MONITOR.

Source documents

Other decisions for Medifocus, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.